N-cyclopropyl-2-[4-(morpholine-2-carbonyl)piperazin-1-yl]propanamide

C15H26N4O3 — CID 119839089

IUPACN-cyclopropyl-2-[4-(morpholine-2-carbonyl)piperazin-1-yl]propanamide
SMILESCC(C(=O)NC1CC1)N1CCN(C(=O)C2CNCCO2)CC1
InChIInChI=1S/C15H26N4O3/c1-11(14(20)17-12-2-3-12)18-5-7-19(8-6-18)15(21)13-10-16-4-9-22-13/h11-13,16H,2-10H2,1H3,(H,17,20)
InChIKeyLSCGSYQPEGZSHE-UHFFFAOYSA-N
MW310.40 g/mol
LogP-1.21
Rot. Bonds4

About N-cyclopropyl-2-[4-(morpholine-2-carbonyl)piperazin-1-yl]propanamide

N-cyclopropyl-2-[4-(morpholine-2-carbonyl)piperazin-1-yl]propanamide (PubChem CID 119839089) has the molecular formula C15H26N4O3 and a molecular weight of 310.40 g/mol. Its IUPAC name is N-cyclopropyl-2-[4-(morpholine-2-carbonyl)piperazin-1-yl]propanamide.

Molecular Properties

Compound NameN-cyclopropyl-2-[4-(morpholine-2-carbonyl)piperazin-1-yl]propanamide
PubChem CID119839089
Molecular FormulaC15H26N4O3
Molecular Weight310.40 g/mol
Exact Mass310.20
IUPAC NameN-cyclopropyl-2-[4-(morpholine-2-carbonyl)piperazin-1-yl]propanamide
SMILESCC(C(=O)NC1CC1)N1CCN(C(=O)C2CNCCO2)CC1
InChIInChI=1S/C15H26N4O3/c1-11(14(20)17-12-2-3-12)18-5-7-19(8-6-18)15(21)13-10-16-4-9-22-13/h11-13,16H,2-10H2,1H3,(H,17,20)
InChIKeyLSCGSYQPEGZSHE-UHFFFAOYSA-N
XLogP-1.21
TPSA73.91 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms22
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500310.40
LogP ≤ 5-1.21
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze N-cyclopropyl-2-[4-(morpholine-2-carbonyl)piperazin-1-yl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-cyclopropyl-2-[4-[(2R,3S)-2-methylmorpholine-3-carbonyl]piperazin-1-yl]propanamide
CID 120938428
N-cyclopropyl-2-[4-(piperidine-4-carbonyl)piperazin-1-yl]propanamide;dihydrochloride
CID 119839032
2-[4-[(2S,5R)-5-(aminomethyl)oxolane-2-carbonyl]piperazin-1-yl]-N-cyclopropylpropanamide
CID 120797474
N-cyclopropyl-2-[4-[(2R)-piperidine-2-carbonyl]piperazin-1-yl]propanamide;dihydrochloride
CID 119839022
morpholin-2-yl(piperidin-1-yl)methanone;hydrochloride
CID 71298615
2-(azepan-1-yl)-N-pyrrolidin-3-ylpropanamide
CID 119450526
2-(4-acetylpiperazin-1-yl)-N-cyclopentylpropanamide
CID 123939055
[4-(2-methoxyethyl)piperazin-1-yl]-morpholin-2-ylmethanone;dihydrochloride
CID 119838568
N-cyclopropyl-2-(1,4-diazepan-1-yl)propanamide
CID 43115733
N-cyclopropyl-2-(1,4-diazepan-1-yl)propanamide;hydrochloride
CID 119925326
(4,4-diethylpiperidin-1-yl)-morpholin-2-ylmethanone
CID 55160831
[(2R)-morpholin-2-yl]-(3-propan-2-yl-5,6,8,9-tetrahydro-[1,2,4]triazolo[4,3-d][1,4]diazepin-7-yl)methanone
CID 95727153

Frequently Asked Questions

What is the IUPAC name of N-cyclopropyl-2-[4-(morpholine-2-carbonyl)piperazin-1-yl]propanamide?
The IUPAC name of N-cyclopropyl-2-[4-(morpholine-2-carbonyl)piperazin-1-yl]propanamide (CID 119839089) is N-cyclopropyl-2-[4-(morpholine-2-carbonyl)piperazin-1-yl]propanamide.
What is the SMILES notation for N-cyclopropyl-2-[4-(morpholine-2-carbonyl)piperazin-1-yl]propanamide?
The canonical SMILES for N-cyclopropyl-2-[4-(morpholine-2-carbonyl)piperazin-1-yl]propanamide is CC(C(=O)NC1CC1)N1CCN(C(=O)C2CNCCO2)CC1.
What is the InChIKey of N-cyclopropyl-2-[4-(morpholine-2-carbonyl)piperazin-1-yl]propanamide?
The InChIKey is LSCGSYQPEGZSHE-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H26N4O3/c1-11(14(20)17-12-2-3-12)18-5-7-19(8-6-18)15(21)13-10-16-4-9-22-13/h11-13,16H,2-10H2,1H3,(H,17,20).
What are the key properties of N-cyclopropyl-2-[4-(morpholine-2-carbonyl)piperazin-1-yl]propanamide?
N-cyclopropyl-2-[4-(morpholine-2-carbonyl)piperazin-1-yl]propanamide has a molecular weight of 310.40 g/mol, XLogP of -1.21, 4 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-cyclopropyl-2-[4-(morpholine-2-carbonyl)piperazin-1-yl]propanamide is sourced from PubChem (CID 119839089), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).